Secondary Prevention of Cardiovascular Events With Long-Term Pravastatin in Patients With Diabetes or Impaired Fasting Glucose
Results from the LIPID trial
Article Information
vol. 26 no. 10 2713-2721
PubMed
Published By
Print ISSN
Online ISSN
History
- July 16, 2003
- December 3, 2002
- Published in print September 26, 2003.
Copyright & Usage
DIABETES CARE
Author Information
- Anthony Keech, MBBS, FRACP1,
- David Colquhoun, MBBS, FRACP2,
- James Best, MD, FRACP3,
- Adrienne Kirby, MSC1,
- R. John Simes, MD, FRACP1,
- David Hunt, MD, FRACP4,
- Wendy Hague, MBBS, MBA1,
- Elaine Beller, MAPPSTAT1,
- Manjula Arulchelvam, MSC1,
- Jennifer Baker, MBBS, MSC1,
- Andrew Tonkin, MD, FRACP5 and
- for the LIPID Study Group
- 1National Health Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia
- 2Wesley Medical Centre, Brisbane, Australia
- 3St. Vincent’s Hospital, Melbourne, Australia
- 4Royal Melbourne Hospital, Melbourne, Australia
- 5National Heart Foundation, Melbourne, Australia
- Address correspondence and reprint requests to Professor Anthony Keech, NHMRC Clinical Trials Centre, Mallett Street Campus, University of Sydney, NSW 2006, Australia. E-mail: enquiry{at}ctc.usyd.edu.au
Statistics from Altmetric.com
Article usage
In this Issue
October 2003, 26(10)
Secondary Prevention of Cardiovascular Events With Long-Term Pravastatin in Patients With Diabetes or Impaired Fasting Glucose
